Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review
Nanomaterials · 13.02.2025 · 15 (4) · 285
DOI: 10.3390/nano15040285 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 13.02.2025. Verfasst von Willem Graham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical, Aerospace, and Biomedical Engineering, University of Tennessee, Knoxville, TN 37996, USA. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering.
Abstract (Originalsprache)
Cancer continues to be a prominent fatal health issue worldwide, driving the urgent need for more effective treatment strategies. The pressing demand has sparked significant interest in the development of advanced drug delivery systems for chemotherapeutics. The advent of nanotechnology offers a groundbreaking approach, presenting a promising pathway to revolutionize cancer treatment and improve patient outcomes. Nanomedicine-based drug delivery systems have demonstrated the capability of improving the pharmacokinetic properties and accumulation of chemotherapeutic agents in cancer sites while minimizing the adverse side effects. Despite these advantages, most NDDSs exhibit only limited improvement in cancer treatment during clinical trials. The recent development of magnetic nanoparticles (MNPs) for biomedical applications has revealed a potential opportunity to further enhance the performance of NDDSs. The magnetic properties of MNPs can be utilized to increase the targeting capabilities of NDDSs, improve the controlled release of chemotherapeutic agents, and weaken the chemoresistance of tumors with magnetic hyperthermia. In this review, we will explore recent advancements in research for NDDSs for oncology applications, how MNPs and their properties can augment the capabilities of NDDSs when complexed with them and emphasize the challenges and safety concerns of incorporating these systems into cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical, Aerospace, and Biomedical Engineering, University of Tennessee, Knoxville, TN 37996, USA.
ORCID-Profile: McKayla Torbett-Dougherty, Shokoufeh Soleimani, Jacqueline Ann Johnson
Förderung
- NIBIB NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Graham, W., Torbett-Dougherty, M., Islam, A., Soleimani, S., Bruce-Tagoe, T. A., & Johnson, J. A. (2025). Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review. Nanomaterials, 15(4), 285. https://doi.org/10.3390/nano15040285
Vancouver
Graham W, Torbett-Dougherty M, Islam A, Soleimani S, Bruce-Tagoe TA, Johnson JA. Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review. Nanomaterials. 2025;15(4):285. doi:10.3390/nano15040285
BibTeX
@article{Graham2025,
author = {Graham, Willem and Torbett-Dougherty, McKayla and Islam, Akm and Soleimani, Shokoufeh and Bruce-Tagoe, Tracy Ann and Johnson, Jacqueline Ann},
title = {Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review},
journal = {Nanomaterials},
year = {2025},
volume = {15},
number = {4},
pages = {285},
doi = {10.3390/nano15040285}
}
EUVIMED